Fludarabine-Melphalan Conditioning for AML and MDS: Alemtuzumab Reduces Acute and Chronic GVHD without Affecting Long-Term Outcomes

✍ Scribed by Koen Van Besien; Rangesh Kunavakkam; Gaby Rondon; Marcos De Lima; Andrew Artz; Betul Oran; Sergio Giralt

• Book ID: 116281020
• Publisher: Elsevier Science
• Year: 2009
• Tongue: English
• Weight: 318 KB
• Volume: 15
• Category: Article
• ISSN: 1083-8791
• DOI: 10.1016/j.bbmt.2009.01.021